P

Inventor

MCCHESNEY JAMES D

US53 patents
⚠️ This page may combine multiple inventors who share the name “MCCHESNEY JAMES D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TAPESTRY PHARMACEUTICALS INC

19 patents
US7745650B2Jun 29, 2010

9,10-α,α-OH-taxane analogs and methods for production thereof

TAPESTRY PHARMACEUTICALS INC28 citations95
US7879904B2Feb 1, 2011

9, 10-α,α-OH-taxane analogs and methods for production thereof

TAPESTRY PHARMACEUTICALS INC21 citations92
US7153946B2Dec 26, 2006

Molecular conjugates for use in treatment of cancer

TAPESTRY PHARMACEUTICALS INC33 citations90
US6825166B2Nov 30, 2004

Molecular conjugates for use in treatment of cancer

TAPESTRY PHARMACEUTICALS INC15 citations81
US11147793B2Oct 19, 2021

Taxane analogs for the treatment of brain cancer

TAPESTRY PHARMACEUTICALS INC1 citations71
US11786504B2Oct 17, 2023

Taxane analogs for the treatment of brain cancer

TAPESTRY PHARMACEUTICALS INC0 citations61
US12583865B2Mar 24, 2026

Biologically active taxane analogs and methods of treatment by oral administration

TAPESTRY PHARMACEUTICALS INC0 citations60
US11873308B2Jan 16, 2024

Biologically active taxane analogs and methods of treatment by oral administration

TAPESTRY PHARMACEUTICALS INC0 citations60
US11220512B2Jan 11, 2022

Biologically active taxane analogs and methods of treatment by oral administration

TAPESTRY PHARMACEUTICALS INC0 citations60
US10639293B2May 5, 2020

9,10-α,α-OH-taxane analogs and methods for production thereof

TAPESTRY PHARMACEUTICALS INC0 citations51
US10238621B2Mar 26, 2019

9,10-α,α-OH-taxane analogs and methods for production thereof

TAPESTRY PHARMACEUTICALS INC0 citations51
US10143677B2Dec 4, 2018

Taxane analogs for the treatment of brain cancer

TAPESTRY PHARMACEUTICALS INC0 citations51
US9820962B2Nov 21, 2017

9, 10-α, α-oh-taxane analogs and methods for production thereof

TAPESTRY PHARMACEUTICALS INC0 citations51
US9402824B2Aug 2, 2016

9,10-α, α-OH-taxane analogs and methods for production thereof

TAPESTRY PHARMACEUTICALS INC0 citations51
US10745408B2Aug 18, 2020

Biologically active taxane analogs and methods of treatment by oral administration

TAPESTRY PHARMACEUTICALS INC0 citations50
US10450323B2Oct 22, 2019

Biologically active taxane analogs and methods of treatment by oral administration

TAPESTRY PHARMACEUTICALS INC0 citations50
US9802951B2Oct 31, 2017

Biologically active taxane analogs and methods of treatment by oral administration

TAPESTRY PHARMACEUTICALS INC0 citations50
US9616043B2Apr 11, 2017

Taxane analogs for the treatment of brain cancer

TAPESTRY PHARMACEUTICALS INC0 citations50
US9132118B2Sep 15, 2015

Taxane analogs for the treatment of brain cancer

TAPESTRY PHARMACEUTICALS INC0 citations50

NAPRO BIOTHERAPEUTICS INC

11 patents
US6281368B1Aug 28, 2001

Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III

NAPRO BIOTHERAPEUTICS INC25 citations91
US6358996B1Mar 19, 2002

Stable isotope labeling of paclitaxel

NAPRO BIOTHERAPEUTICS INC24 citations88
US6495705B2Dec 17, 2002

Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes

NAPRO BIOTHERAPEUTICS INC14 citations84
US6143902ANov 7, 2000

C-2 hydroxyl protected-N-acyl (2R,3S)-3-phenylisoserine N-imido activated esters and method for production thereof

NAPRO BIOTHERAPEUTICS INC6 citations73
US6136999AOct 24, 2000

C-2 hydroxyl protected-n-acyl (2R,3S)-3-phenylisoserine substituted phenyl activated esters and method for production thereof

NAPRO BIOTHERAPEUTICS INC7 citations73
US6066749AMay 23, 2000

Method for conversion of C-2'-O-protected-10-hydroxy taxol to c-2'-O-protected taxol:useful intermediates in paclitaxel synthesis

NAPRO BIOTHERAPEUTICS INC13 citations72
US6048990AApr 11, 2000

Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position

NAPRO BIOTHERAPEUTICS INC14 citations72
US5914411AJun 22, 1999

Alternate method for acylating 10-deacetylbaccatin III selectively at the C-10 position

NAPRO BIOTHERAPEUTICS INC10 citations72
US6479679B1Nov 12, 2002

Two-step conversion of protected taxane ester to paclitaxel

NAPRO BIOTHERAPEUTICS INC2 citations62
US6448417B1Sep 10, 2002

Methods and useful intermediates for paclitaxel synthesis from C-7, C-10 di-cbz 10-deacetylbaccatin III

NAPRO BIOTHERAPEUTICS INC3 citations61
US6452025B1Sep 17, 2002

Three-step conversion of protected taxane ester to paclitaxel

NAPRO BIOTHERAPEUTICS INC1 citations52

MCCHESNEY JAMES D

10 patents

ARBOR THERAPEUTICS LLC

6 patents

UNIV MISSISSIPPI

2 patents

ZYGMUNT JAN

1 patent

IRONSTONE SEPARATIONS INC

1 patent

Showing the top 50 of 53 patents by PatentIndex Score.